Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Titel:
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
Auteur:
Lebellec, Loïc Chauffert, Bruno Blay, Jean-Yves Le Cesne, Axel Chevreau, Christine Bompas, Emmanuelle Bertucci, François Cupissol, Didier Fabbro, Michel Saada-Bouzid, Esma Duffaud, Florence Feuvret, Loïc Bonneville-Levard, Alice Bay, Jacques-Olivier Vauleon, Elodie Vinceneux, Armelle Noel, Georges Penel, Nicolas Mir, Olivier